Provided by Tiger Fintech (Singapore) Pte. Ltd.

Immix Biopharma, Inc.

1.50
-0.0800-5.06%
Post-market: 1.500.00000.00%16:05 EDT
Volume:33.51K
Turnover:51.58K
Market Cap:41.58M
PE:-1.96
High:1.65
Open:1.58
Low:1.50
Close:1.58
Loading ...
Feb 09, 2022

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Jan 25, 2022

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 19, 2022

Major Issues Report

8-K - Current report
Jan 12, 2022

Major Issues Report

8-K - Current report
Jan 03, 2022

Major Issues Report

8-K - Current report
Dec 28, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Dec 20, 2021

Major Issues Report

8-K - Current report
Dec 13, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 13, 2021

Correspondence

CORRESP [Cover] - Correspondence
Dec 01, 2021

[Supp]Public Prospectus

FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Nov 04, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 28, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 15, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 15, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Oct 06, 2021

Correspondence

CORRESP [Cover] - Correspondence
Oct 06, 2021

[Amend]Public Prospectus

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
Sep 17, 2021

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
Sep 16, 2021

Correspondence

CORRESP [Cover] - Correspondence